PTIX logo

Protagenic Therapeutics (PTIX) Operating Expenses

Annual Operating Expenses

$4.53 M
+$969.20 K+27.24%

December 31, 2023


Summary


Performance

PTIX Operating Expenses Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherPTIXexpensesmetrics:

Quarterly Operating Expenses

$652.10 K
-$1.02 M-60.89%

September 30, 2024


Summary


Performance

PTIX Quarterly Operating Expenses Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherPTIXexpensesmetrics:

Operating Expenses Formula

Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses

PTIX Operating Expenses Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+27.2%-60.9%
3 y3 years+77.4%-60.9%
5 y5 years+95.6%-60.9%

PTIX Operating Expenses Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+27.2%-62.5%+2.4%
5 y5-yearat high+117.0%-62.5%+33.4%
alltimeall time-87.9%-100.0%-95.5%+106.6%

Protagenic Therapeutics Operating Expenses History

DateAnnualQuarterly
Sep 2024
-
$652.10 K(-60.9%)
Jun 2024
-
$1.67 M(-4.1%)
Mar 2024
-
$1.74 M(+43.4%)
Dec 2023
$4.53 M(+27.2%)
$1.21 M(-15.3%)
Sep 2023
-
$1.43 M(+25.2%)
Jun 2023
-
$1.14 M(+54.7%)
Mar 2023
-
$739.30 K(+12.7%)
Dec 2022
$3.56 M(-14.1%)
$655.80 K(-29.0%)
Sep 2022
-
$924.10 K(+45.1%)
Jun 2022
-
$636.70 K(-52.5%)
Mar 2022
-
$1.34 M(+55.7%)
Dec 2021
$4.14 M(+62.3%)
$861.20 K(+12.7%)
Sep 2021
-
$764.20 K(-41.6%)
Jun 2021
-
$1.31 M(+8.5%)
Mar 2021
-
$1.21 M(+124.7%)
Dec 2020
$2.55 M(+22.3%)
$536.90 K(-50.8%)
Sep 2020
-
$1.09 M(+123.4%)
Jun 2020
-
$488.90 K(-6.1%)
Mar 2020
-
$520.70 K(-29.4%)
Dec 2019
$2.09 M(-9.9%)
$737.20 K(+288.8%)
Sep 2019
-
$189.60 K(-62.5%)
Jun 2019
-
$505.30 K(-22.7%)
Mar 2019
-
$654.00 K(+24.8%)
Dec 2018
$2.31 M(-2.2%)
$524.20 K(+5.2%)
Sep 2018
-
$498.10 K(-27.3%)
Jun 2018
-
$685.10 K(+12.9%)
Mar 2018
-
$606.70 K(-14.4%)
Dec 2017
$2.37 M(+29.3%)
$708.80 K(+34.5%)
Sep 2017
-
$527.00 K(+11.7%)
Jun 2017
-
$471.60 K(-28.3%)
Mar 2017
-
$657.90 K(+18.3%)
Dec 2016
$1.83 M(+272.6%)
$556.30 K(+22.3%)
Sep 2016
-
$454.80 K(-8.4%)
Jun 2016
-
$496.70 K(+54.4%)
Mar 2016
-
$321.60 K(+113.0%)
Dec 2015
-
$151.00 K(+16.2%)
Sep 2015
-
$130.00 K(+14.0%)
Jun 2015
$491.00 K(-49.6%)
$114.00 K(-5.8%)
Mar 2015
-
$121.00 K(-11.7%)
Dec 2014
-
$137.00 K(+16.1%)
Sep 2014
-
$118.00 K(-9.2%)
Jun 2014
$975.00 K(+28.6%)
$130.00 K(-67.3%)
Mar 2014
-
$398.00 K(+64.5%)
Dec 2013
-
$242.00 K(+17.5%)
Sep 2013
-
$206.00 K(-92.9%)
Jun 2013
$758.00 K(-94.9%)
-
Sep 2011
-
$2.92 M(-9.5%)
Jun 2011
-
$3.23 M(+10.7%)
Mar 2011
-
$2.91 M(-3.8%)
Dec 2010
$14.77 M
$3.03 M(-21.5%)
DateAnnualQuarterly
Sep 2010
-
$3.86 M(-7.3%)
Jun 2010
-
$4.16 M(+12.1%)
Mar 2010
-
$3.71 M(-38.3%)
Dec 2009
$26.79 M(-16.0%)
$6.02 M(-5.6%)
Sep 2009
-
$6.38 M(-6.1%)
Jun 2009
-
$6.79 M(-10.8%)
Mar 2009
-
$7.61 M(-283.4%)
Dec 2008
$31.90 M(-14.9%)
-$4.15 M(-142.1%)
Sep 2008
-
$9.85 M(-13.1%)
Jun 2008
-
$11.32 M(-22.6%)
Mar 2008
-
$14.64 M(+6.7%)
Dec 2007
$37.47 M(+125.0%)
$13.71 M(+22.3%)
Sep 2007
-
$11.21 M(+52.3%)
Jun 2007
-
$7.36 M(+41.9%)
Mar 2007
-
$5.19 M(>+9900.0%)
Dec 2006
$16.65 M(>+9900.0%)
-
Oct 2006
-
$14.40 K(-100.1%)
Jul 2006
-
-$9.86 M(-285.1%)
Jul 2006
$71.00 K(-24.9%)
-
Apr 2006
-
$5.33 M(>+9900.0%)
Jan 2006
-
$9700.00(-80.8%)
Oct 2005
-
$50.40 K(-97.1%)
Jul 2005
$94.50 K(>+9900.0%)
-
Jul 2004
$0.00(-100.0%)
-
Apr 2003
-
$1.75 M(+8.8%)
Jan 2003
-
$1.61 M(-9.4%)
Oct 2002
-
$1.77 M(-21.3%)
Jul 2002
$8.55 M(-0.7%)
$2.25 M(+3.5%)
Apr 2002
-
$2.18 M(+2.1%)
Jan 2002
-
$2.13 M(+7.0%)
Oct 2001
-
$1.99 M(-14.2%)
Jul 2001
$8.61 M(+10.8%)
$2.32 M(+8.5%)
Apr 2001
-
$2.14 M(-3.9%)
Jan 2001
-
$2.23 M(+15.7%)
Oct 2000
-
$1.92 M(+284.0%)
Jul 2000
$7.77 M(-3.8%)
$501.00 K(-80.4%)
Apr 2000
-
$2.56 M(+6.5%)
Jan 2000
-
$2.40 M(0.0%)
Oct 1999
-
$2.40 M(+313.8%)
Jul 1999
$8.08 M(+16.3%)
$580.00 K(-78.5%)
Apr 1999
-
$2.70 M(+12.5%)
Jan 1999
-
$2.40 M(0.0%)
Oct 1998
-
$2.40 M(+270.9%)
Jul 1998
$6.95 M(-8.6%)
$647.00 K(-73.0%)
Apr 1998
-
$2.40 M(+20.0%)
Jan 1998
-
$2.00 M(0.0%)
Oct 1997
-
$2.00 M(+17.6%)
Jul 1997
$7.60 M
$1.70 M(-10.5%)
Apr 1997
-
$1.90 M(-9.5%)
Jan 1997
-
$2.10 M

FAQ

  • What is Protagenic Therapeutics annual total operating expenses?
  • What is the all time high annual operating expenses for Protagenic Therapeutics?
  • What is Protagenic Therapeutics annual operating expenses year-on-year change?
  • What is Protagenic Therapeutics quarterly total operating expenses?
  • What is the all time high quarterly operating expenses for Protagenic Therapeutics?
  • What is Protagenic Therapeutics quarterly operating expenses year-on-year change?

What is Protagenic Therapeutics annual total operating expenses?

The current annual operating expenses of PTIX is $4.53 M

What is the all time high annual operating expenses for Protagenic Therapeutics?

Protagenic Therapeutics all-time high annual total operating expenses is $37.47 M

What is Protagenic Therapeutics annual operating expenses year-on-year change?

Over the past year, PTIX annual total operating expenses has changed by +$969.20 K (+27.24%)

What is Protagenic Therapeutics quarterly total operating expenses?

The current quarterly operating expenses of PTIX is $652.10 K

What is the all time high quarterly operating expenses for Protagenic Therapeutics?

Protagenic Therapeutics all-time high quarterly total operating expenses is $14.64 M

What is Protagenic Therapeutics quarterly operating expenses year-on-year change?

Over the past year, PTIX quarterly total operating expenses has changed by -$1.02 M (-60.89%)